This work indicated that immune checkpoint inhibition and restoration of T-cell function might not be enough as a therapeutic approach, as the ability of CD8+ T cells to reach closer to the tumor islets and efficiently infiltrate them is an equally important parameters for them to successfully exert their anti-tumor functions. The gene discussed is CD8A; the disease is neoplasm.